Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


UTD THERAPEUTIC   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2021202020192018201720162015201420132012
Period End Date12/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/2012
Service sales--------------------
License fees--------------------
Net product sales1,685.501,483.301,448.801,627.801,725.301,598.801,460.601,279.501,106.94906.12
Service sales to affiliates--------------------
Other revenues------------5.209.0010.049.95
Grant revenue--------------------
Total Revenues1,685.501,483.301,448.801,627.801,725.301,598.801,465.801,288.501,116.98916.08
Cost of product sales122.50108.10117.60198.70105.7072.7069.00125.90131.13119.30
Cost of service sales--------------------
Research and development540.10357.701,182.60357.90264.60147.60245.10242.50299.35173.39
Selling, general and administrative467.00423.90336.20265.80330.10316.80452.70381.30394.01201.75
Sales and marketing--------------------
Settlement of loss contingency--------(210.00)0.00--------
Total Operating Expenses1,129.60889.701,636.40822.40910.40--766.80749.70--494.43
Operating Income (Loss)555.90593.60(187.60)805.40814.901,061.70699.00538.80292.50421.65
Interest expense18.6023.5044.2013.909.003.904.7017.6018.0616.64
Write-down of investment--------------------
Impairment of cost method investment--------49.600.000.00------
Impairments of investments in privately-held companies2.309.100.0053.50------------
Gain on sale of intangible asset------------350.00--0.00--
Gain (Loss) on marketable investments--------------------
Equity loss in affiliate--------------------
Interest income16.7028.6044.2028.6010.903.50--------
Other income (expense)42.2049.3022.60(7.70)2.30(1.10)0.104.004.4635.66
Total other (expense) income, net38.0045.3022.60(46.50)(45.40)537.10345.40(13.60)824.4919.03
Income before income tax593.90638.90(165.00)758.90769.501,060.201,044.40525.20278.90440.67
Current- Foreign----------------2.160.66
Current: Federal------------351.20166.40120.0383.91
Current: State------------37.0021.4020.1013.95
Deferred: Federal------------(2.70)(3.10)(37.71)37.26
Deferred: State------------7.300.40(9.06)(0.42)
Deferred: Foreign--------------------
Income tax provision (benefit)118.10124.10(60.50)169.70351.60346.50392.80185.10104.34136.23
Other Non-Current: Federal--------------------
Other Non-Current: State--------------------
Other non-current: Foreign----------------(1.06)0.18
Income from Continuing Operations--------------------
Income from Discontinued Operations--------------------
Gain on disposal of discontinued operations, net of tax--------------------
Net Income (loss) Available to Common Shareholders475.80514.80(104.50)589.20417.90713.70651.60340.10174.56304.44
Income from continuing operations -EPS (Basic)--------------------
Discontinued operations EPS (Basic)--------------------
Net Earnings Per Share (Basic)10.6011.65(2.39)13.549.5016.2914.177.063.495.84
Income from continuing operations -EPS (Diluted--------------------
Discontinued operations EPS (Diluted)--------------------
Net Earnings Per Share (Diluted)10.0611.54(2.39)13.399.3115.2512.726.283.285.71
Weighted Average Shares Outstanding (Basic)44.9044.2043.8043.5044.0043.8046.0048.2050.0852.09
Weighted Average Shares Outstanding (Diluted)47.3044.6043.8044.0044.9046.8051.2054.2053.2353.28